TRV GP Iv, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 727,082 shares at $7.04 ($5.1M) on 2025-09-16, disclosed to the SEC on 2025-09-17.
Open-market sale of $5.1M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.04 | 363,541 | $2.6M | 50.0% |
| 2 | $7.04 | 363,541 | $2.6M | 50.0% |
| Total | $7.04 avg | 727,082 | $5.1M | 100% |
| Filing → |
| TNGX | SELL | 2025-09-09 | $5.7M | — | Filing → |
| TNGX | SELL | 2024-09-17 | $710K | — | Filing → |
| TNGX | SELL | 2024-09-09 | $867K | — | Filing → |